Amneal Pharmaceuticals, Inc. (AMRX) Revenue Growth
Amneal Pharmaceuticals, Inc. (AMRX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2018-12-31 | 60.13% |
| 2019-12-31 | 5.88% |
| 2020-12-31 | 15.67% |
| 2021-12-31 | 4.40% |
| 2022-12-31 | 4.53% |
| 2023-12-31 | 8.20% |
| 2024-12-31 | 16.73% |
| 2025-12-31 | 8.05% |
How AMRX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| CI | The Cigna Group | 11.24% |
| AMGN | Amgen Inc. | 9.95% |
| VNDA | Vanda Pharmaceuticals Inc. | 8.72% |
| BDX | Becton Dickinson and Company | 8.24% |
| BAX | Baxter International Inc. | 5.72% |
These are five companies in the same sector as AMRX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Amneal Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("AMRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AMRX | $17.47 | -0.40% | 1.74M |
| 3 | ||||
| 4 | ||||
| 5 |